A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats.
暂无分享,去创建一个
I. Wilson | A. J. Wilson | R. Plumb | E. Lenz | J. Granger | C. Stumpf | I D Wilson | H. Major | E M Lenz | H Major | R. Williams | R Plumb | R Williams | A J Wilson | J Granger | C Stumpf
[1] Ian D Wilson,et al. HPLC-MS-based methods for the study of metabonomics. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[2] I. Wilson,et al. Cyclosporin A-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics. , 2004, Journal of pharmaceutical and biomedical analysis.
[3] O. Fiehn,et al. Metabolite profiling for plant functional genomics , 2000, Nature Biotechnology.
[4] M. Tomita,et al. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. , 2003, Journal of proteome research.
[5] J. Nicholson,et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.
[6] M. Krempf,et al. Determination of alpha-tocopherol in plasma, platelets and erythrocytes of type I and type II diabetic patients by high-performance liquid chromatography. , 1990, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.
[7] I. Wilson,et al. A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1H NMR and HPLC-TOF/MS: time dependent changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity. , 2004, The Analyst.
[8] J. Lindon,et al. Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.
[9] J. Lindon,et al. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.
[10] W. Banz,et al. A cooperative interaction between soy protein and its isoflavone-enriched fraction lowers hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male Sprague-Dawley rats. , 2000, The Journal of nutrition.
[11] G. Mazzucco,et al. Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] L. V. Van Gaal,et al. Evolution of Serum α‐Tocopherol in the Postprandial and Postabsorptive Phases in Type 1 Diabetes Mellitus , 2004 .
[13] M. Azain,et al. Altered hepatic metabolism of free fatty acids underlying hypersecretion of very low density lipoproteins in the genetically obese Zucker rats. , 1982, The Journal of biological chemistry.
[14] G. Tint,et al. Comparative effect of dietary sitosterol on plasma sterols and cholesterol and bile acid synthesis in a sitosterolemic homozygote and heterozygote subject. , 1997, Journal of the American College of Nutrition.
[15] D. Kell,et al. Metabolic profiling using direct infusion electrospray ionisation mass spectrometry for the characterisation of olive oils. , 2002, The Analyst.
[16] Jianren Gu,et al. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. , 2005, Analytical chemistry.
[17] Anthony F. P. Nash,et al. A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. , 2003, Journal of pharmaceutical and biomedical analysis.
[18] E. Kökoğlu,et al. The transport of vitamin E in plasma and its correlation to plasma lipoproteins in non-insulin-dependent diabetes mellitus. , 1991, Diabetes research and clinical practice.
[19] Alan Hutson,et al. Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics , 2005, International journal of cancer.
[20] I. Wilson,et al. A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. , 2005, Journal of pharmaceutical and biomedical analysis.
[21] W. Dunn,et al. Measuring the metabolome: current analytical technologies. , 2005, The Analyst.
[22] A. Cicero,et al. Effects of a new low dose soy protein/β-sitosterol association on plasma lipid levels and oxidation , 2004, European journal of nutrition.
[23] Henrik Antti,et al. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. , 2003, Toxicology and applied pharmacology.
[24] Joshua D. Knowles,et al. Closed-loop, multiobjective optimization of analytical instrumentation: gas chromatography/time-of-flight mass spectrometry of the metabolomes of human serum and of yeast fermentations. , 2005, Analytical chemistry.
[25] D. Grobbee,et al. α-Tocopherol levels in plasma in new-onset, insulin-dependent diabetes mellitus , 2004 .
[26] Leo L. Cheng,et al. Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. , 2005, Cancer research.
[27] M. Rantalainen,et al. The comparative metabonomics of age-related changes in the urinary composition of male Wistar-derived and Zucker (fa/fa) obese rats. , 2006, Molecular bioSystems.